个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Requirements for human-induced pluripotent stem cells.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhang Ying[1,2] * ; Wei Jun[2,3] * ; Cao Jiani[2,4,5] * ; Zhang Kehua[6] * ; Peng Yaojin[2,4,5] ; Deng Hongkui[7] ; Kang Jiuhong[8] ; Pan Guangjin[9] ; Zhang Yong[2,10] ; Fu Boqiang[2,11] ; Hu Shijun[2,12] ; Na Jie[13] ; Liu Yan[14] ; Wang Lei[2,4,5] ; Liang Lingmin[2,4,5] ; Zhu Huanxin[2,4,5] ; Zhang Yu[2,3] ; Jin Zi-Bing[15] ; Hao Jie[2,4,5,*2] ; Ma Aijin[2,16,*3] ; Zhao Tongbiao[2,4,5,*2] ; Yu Junying[1,2,*1] ;
机构： [1]Nuwacell Biotechnologies Co., Ltd., Hefei City, China. [2]Chinese Society for Stem Cell Research, Shanghai, China. [3]Zephyrm Biotechnologies Co., Ltd., Beijing, China. [4]State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China. [5]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. [6]Institutes for Biological Products Control, Cell Collection and Research Center, National Institutes for Food and Drug Control, Beijing, China. [7]Peking University Stem Cell Research Center and Cell Biology Department, Peking University Health Science Center, Beijing, China. [8]Frontier Science Center for Stem Cell Research, National Stem Cell Translational Resource Center, School of Life Sciences and Technology, Tongji University, Shanghai, China. [9]Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. [10]HHLIFE Company Inc, Shenzhen, China. [11]National Institute of Metrology, Beijing, China. [12]Department of Cardiovascular Surgery of The First Affiliated Hospital & Institute for Cardiovascular Science, Medical College, Soochow University, Suzhou, China. [13]Center for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing, China. [14]Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing Medical University, Nanjing, China. [15]Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [16]Beijing Technology and Business University, Beijing, China.
出处：
DOI： 10.1111/cpr.13182
ISSN：

摘要：
'Requirements for Human-Induced Pluripotent Stem Cells' is the first set of guidelines on human-induced pluripotent stem cells in China, jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research. This standard specifies the technical requirements, test methods, and instructions for use, labeling, packaging, storage, transportation, and waste handling for human-induced pluripotent stem cells, which apply to the production and quality control of human-induced pluripotent stem cells. It was released by the Chinese Society for Cell Biology on 9 January 2021 and came into effect on 9 April 2021. We hope that the publication of these guidelines will promote institutional establishment, acceptance, and execution of proper protocols and accelerate the international standardization of human-induced pluripotent stem cells for applications.© 2022 The Authors. Cell Proliferation published by John Wiley & Sons Ltd.

基金：
Ministry of Science and Technology of the People's Republic of China,Grant/Award Number: 2017YFA0105300, 2018YFA0108401 and 2018YFE0204400; Chinese Academy of Sciences, Grant/ Award Number: XDA16040501, XDA16040502 and XDA16040504
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 2 区 生物学
小类 | 2 区 细胞生物学
最新[2025]版：
大类 | 1 区 生物学
小类 | 1 区 细胞生物学
JCR分区：
出版当年[2020]版：
Q1 CELL BIOLOGY
最新[2024]版：
Q2 CELL BIOLOGY

影响因子： 最新[2024版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [1]Nuwacell Biotechnologies Co., Ltd., Hefei City, China. [2]Chinese Society for Stem Cell Research, Shanghai, China.
共同第一作者：
通讯作者：
通讯机构： [1]Nuwacell Biotechnologies Co., Ltd., Hefei City, China. [2]Chinese Society for Stem Cell Research, Shanghai, China. [4]State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China. [5]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. [16]Beijing Technology and Business University, Beijing, China. [*1]Nuwacell Biotechnologies Co., Ltd., Hefei City, Anhui Province, China [*2]National Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. [*3]Beijing Technology and Business University, Beijing, China
推荐引用方式(GB/T 7714)：
Zhang Ying,Wei Jun,Cao Jiani,et al.Requirements for human-induced pluripotent stem cells.[J].CELL PROLIFERATION.2022,55(4):doi:10.1111/cpr.13182.
APA：
Zhang Ying,Wei Jun,Cao Jiani,Zhang Kehua,Peng Yaojin...&Yu Junying.(2022).Requirements for human-induced pluripotent stem cells..CELL PROLIFERATION,55,(4)
MLA：
Zhang Ying,et al."Requirements for human-induced pluripotent stem cells.".CELL PROLIFERATION 55..4(2022)

资源点击量：28494 今日访问量：0 总访问量：1584 更新日期：2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)